Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Lee

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Cell Reports. Medicine|April 30, 2026
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
JACC. Advances|March 21, 2025
Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative ReviewMayank Dalakoti, Norman H Y Lin, Jonathan Yap, et al.
JACC. Advances|March 22, 2025
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions: A Narrative ReviewMayank Dalakoti, Norman H Y Lin, Jonathan Yap, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Cell Reports. Medicine|April 30, 2026
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
JACC. Advances|March 21, 2025
Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative ReviewMayank Dalakoti, Norman H Y Lin, Jonathan Yap, et al.
JACC. Advances|March 22, 2025
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions: A Narrative ReviewMayank Dalakoti, Norman H Y Lin, Jonathan Yap, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Pageof 8